These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
24. Effect of coadministration of procainamide and isoniazid on each other's acetylation pathway. Schneck DW; Sprouse JS; Shiroff RA; Vary JE; DeWitt FO; Hayes AH Pharmacology; 1979; 18(1):34-41. PubMed ID: 419159 [TBL] [Abstract][Full Text] [Related]
25. [Clinical relevance of N-acetyltransferase type 2 (NAT2) genetic polymorphism]. Furet Y; Bechtel Y; Le Guellec C; Bechtel PR; Autret-Leca E; Paintaud G Therapie; 2002; 57(5):427-31. PubMed ID: 12611196 [TBL] [Abstract][Full Text] [Related]
26. Drugs and genes. Motulsky AG Ann Intern Med; 1969 Jun; 70(6):1269-72. PubMed ID: 4182785 [No Abstract] [Full Text] [Related]
27. Polymorphic N-acetylation of phenelzine and monoacetylhydrazine by highly purified rabbit liver isoniazid N-acetyltransferase. Hein DW; Weber WW Drug Metab Dispos; 1982; 10(3):225-9. PubMed ID: 6125354 [TBL] [Abstract][Full Text] [Related]
28. The use of a three compartment in vitro model to investigate the role of hepatic drug metabolism in drug-induced blood dyscrasias. Tingle MD; Park BK Br J Clin Pharmacol; 1993 Jul; 36(1):31-8. PubMed ID: 8373710 [TBL] [Abstract][Full Text] [Related]
29. Polymorphic acetylation of nitrazepam. Karim AK; Evans DA J Med Genet; 1976 Feb; 13(1):17-9. PubMed ID: 775091 [TBL] [Abstract][Full Text] [Related]
30. A unique pharmacogenetic expression of the N-acetylation polymorphism in the inbred hamster. Hein DW; Omichinski JG; Brewer JA; Weber WW J Pharmacol Exp Ther; 1982 Jan; 220(1):8-15. PubMed ID: 7053425 [TBL] [Abstract][Full Text] [Related]
31. A rapid method for determination of acetylation phenotype using dapsone. Philip PA; Roberts MS; Rogers HJ Br J Clin Pharmacol; 1984 Apr; 17(4):465-9. PubMed ID: 6721993 [TBL] [Abstract][Full Text] [Related]
32. The effect of isoniazid and other drugs on the acetylation of procainamide in the intact rat. Sprouse JS; Schneck DW; Hayes AH J Pharmacol Exp Ther; 1978 Dec; 207(3):698-704. PubMed ID: 731425 [TBL] [Abstract][Full Text] [Related]
33. Plasma hydrazine concentrations in man after isoniazid and hydralazine administration. Blair IA; Mansilla Tinoco R; Brodie MJ; Clare RA; Dollery CT; Timbrell JA; Beever IA Hum Toxicol; 1985 Mar; 4(2):195-202. PubMed ID: 4007883 [TBL] [Abstract][Full Text] [Related]
34. Drugs and genes: therapeutic implications. Chapman CJ Drugs; 1977 Aug; 14(2):120-7. PubMed ID: 891426 [No Abstract] [Full Text] [Related]
36. Kidney disease and drug metabolism. Reidenberg MM Med Clin North Am; 1974 Sep; 58(5):1059-62. PubMed ID: 4608133 [No Abstract] [Full Text] [Related]
37. Active drug metabolites and renal failure. Drayer DE Am J Med; 1977 Apr; 62(4):486-9. PubMed ID: 851118 [TBL] [Abstract][Full Text] [Related]
38. Determination of acetylator phenotype in Sri Lankans. Perera PL; Weerasinghe WM Ceylon Med J; 1987 Mar; 32(1):29-34. PubMed ID: 3690726 [No Abstract] [Full Text] [Related]
39. Ageing and acetylator phenotype. Gachályi B; Vas A; Káldor A Eur J Clin Pharmacol; 1985; 29(3):377. PubMed ID: 4076335 [No Abstract] [Full Text] [Related]
40. Is the patient a fast or a slow acetylator? Drug Ther Bull; 1974 Mar; 12(6):21-2. PubMed ID: 4457304 [No Abstract] [Full Text] [Related] [Previous] [Next] [New Search]